<DOC>
	<DOC>NCT00587444</DOC>
	<brief_summary>Study has been completed and is in the data analysis and manuscript writing phase of the project.</brief_summary>
	<brief_title>Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Adult male and nonpregnant female patients scheduled for elective cardiac surgery requiring CPB will be eligible for enrollment. Age less than 18 or greater than 90 years; emergency surgery Circulatory arrest Combined noncardiac procedures such as carotid endarterectomy Congenital heart repair OffCPB coronary artery bypass grafting (CABG) Clotting disorder Fibrinolytic agents (e.g. streptokinase), severe hepatic disease Aprotinin use Cooling &lt; 28 degrees C during CPB Dialysis dependent renal failure; and Platelet receptor GP3a/2b antagonists medication received within 48 hours of surgery. Patients that are not receiving tranexamic acid (TA) intraoperatively will be excluded.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>heparin management</keyword>
</DOC>